Literature DB >> 8871610

Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.

X Zhang1, L Li, J Choe, S Krajewski, J C Reed, C Thompson, Y S Choi.   

Abstract

CD40--CD40L interactions between resting B cells and activated T cells are essential for germinal center formation. It has been shown that CD40L can induce both Fas expression and susceptibility to Fas-mediated killing in B cells, while anti-Ig can partially rescue B cells from Fas-mediated killing. However, the intracellular mechanism for this phenomenon is not known. We examined the expression of Fas and bcl-2 family gene products, such as Bcl-2, Bcl-x, Bax, and Mcl-1, in human tonsillar B cells. The activation of naive B cells by CD40L induced transient expression of Bcl-xL. As the Bcl-xL level decreased in CD40-activated B cells, the cells became susceptible to apoptosis by anti-Fas antibodies. Though anti-Ig did not change the Fas expression, it protected CD40-activated B cells from Fas-mediated killing by up-regulating Bcl-xL expression. The addition of anti-Ig did not significantly change Bcl-2, Bax, and Mcl-1 levels compared to those of B cells activated by CD40L alone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871610     DOI: 10.1006/cimm.1996.0260

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

3.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

4.  TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Authors:  Ali I Kuraishy; Samuel W French; Mara Sherman; Marco Herling; Dan Jones; Randolph Wall; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

Review 5.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

6.  B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Authors:  Nadine Voelxen; Claudia Wehr; Sylvia Gutenberger; Baerbel Keller; Miriam Erlacher; Cecilia Dominguez-Conde; Daniela Bertele; Florian Emmerich; Milena Pantic; Stefanie Jennings; Mirzokhid Rakhmanov; Christian Foerster; Uwe M Martens; Uwe Platzbecker; Hans-Hartmut Peter; Paul Fisch; Kaan Boztug; Hermann Eibel; Ulrich Salzer; Klaus Warnatz
Journal:  Immunol Cell Biol       Date:  2016-04-29       Impact factor: 5.126

Review 7.  Differentiation and apoptosis of human germinal center B-lymphocytes.

Authors:  Y S Choi
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

8.  Bcl-x(L) expression in vivo in rheumatoid synovium.

Authors:  S Busteed; M W Bennett; C Molloy; A Houston; M A Stone; F Shanahan; M G Molloy; J O'Connell
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

9.  Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.

Authors:  Andrea Pellegrini; Eugenio Antonio Carrera-Silva; Alfredo Arocena; Roxana Carolina Cano; Maria Pilar Aoki; Susana Gea
Journal:  Med Microbiol Immunol       Date:  2011-03-24       Impact factor: 3.402

10.  Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients.

Authors:  Vineeta Chattree; Neena Khanna; Vandana Bisht; D N Rao
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.